Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Seagen

Why Wall Street Gave Up on Pfizer—and Why That May Be a Mistake

With activist investors gone and revenue stabilizing, the undervalued pharmaceutical giant offers a compelling chance for value investors in the coming year.

MarketBeat

How seaweed is a powerful, yet surprising, climate solution

Picture a place at the centre of a global seaweed revolution. I’ll bet the small English seaside town of Paignton in south Devon is not what comes to mind. A decade ago, I moved from the edge of Dartmoor to the coast. It was about a simple change in work-life…

The Conversation

Pfizer's 7.5% Dividend: Income Haven or House of Cards?

Pfizer's high dividend yield warrants scrutiny regarding its sustainability, given changing revenues and pipeline investments.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

This Dividend Stock Yields Nearly 8% and Trades at Depressed Valuations: Time to Buy?

Amid the continued decline in Pfizer stock, its dividend yield has risen to almost 8%. While the stock might not be a screaming buy, it now seems to have limited downside.

Barchart

The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

Fortune

This Dividend Stock Has Plunged Ahead of Trump’s Inauguration. Here Are 3 Reasons Investors Should Still Buy It.

For savvy investors, Pfizer could be an undervalued stock to buy here.

Barchart

Pfizer: 4 Reasons to Buy This Stock

Pharmaceutical giant Pfizer Inc. (NYSE: PFE) stock is trading back down near its pandemic lows. Every time it attempts to climb over the $30 mark, something ca

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

As activist Starboard engages constructively, here’s a potent prescription for Pfizer’s future success under Dr. Bourla’s watch

Pfizer is getting back on track—but an even more potent prescription for success could be in the cards for the pharmaceutical giant under.

Fortune

Is This Overlooked Dividend Stock Yielding Almost 6% a Good Turnaround Play?

Despite its dividend yield of nearly 6%, Pfizer stock has failed to win over investors and is in the red YTD. Can the stock finally stage a turnaround, as activist investor Starboard Value has reportedly taken a stake in the company?

Barchart

Pfizer CEO on moving beyond COVID vaccines to become a leader in cancer and obesity treatments

Pfizer's CEO Albert Bourla is trying to reposition the global pharmaceutical giant for a post-pandemic world

The Independent UK

2 Dividend Stocks to Buy in August If the Market Crash Scares You

Volatility is back on Wall Street, which is bound to scare some investors. Meanwhile, Pfizer and Starbucks are two high dividend names with limited downside which conservative investors can consider now.

Barchart

2 Defensive Stocks to Buy Now as 'Higher For Longer' Woes Rattle Markets

U.S. stocks fell yesterday as the 10-year Treasury yield rose above 4.5% amid sticky inflation. As markets turn volatile, Pfizer and Apple look like two defensive names worth considering.

Barchart

Should You Buy These 2 Dividend Stocks Yielding More Than 5% Right Now?

There are other reasons to consider buying a dividend stock besides the high yield. Here's a closer look at two stocks that offer yields over 5% right now.

Barchart

Pfizer Stock 2025 Forecast: Will PFE Go Up Long Term?

Pfizer stock is trading at price levels last seen in 2016. The 2025 forecast for PFE stock looks positive, though, and it should go up over the medium to long term.

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

International Business Times

Pfizer Shares Tumble On Disappointing 2024 Profit Outlook

Pfizer issued a disappointing 2024 forecast Wednesday, denting shares as the company navigates a profound plunge in sales tied to the Covid-19 pandemic.

International Business Times

Pfizer Expects To Complete Purchase Of Seagen On Thursday

Pfizer announced Tuesday that it expects to complete this week its $43 billion acquisition of cancer-focused biotech company Seagen after clearing key regulatory hurdles.

Barchart

Is Pfizer Stock a Buy Near 52-Week Lows for Its 5.08% Yield?

Pfizer stock faces a steep patent cliff, but it's taken steps to offset the coming pressures. Will it be enough?

Barchart

2 Undervalued Dividend Stocks with 5% Yields To Buy Near 52-Week Lows

Shares of Pfizer and Citigroup are languishing near their 52-week lows. However, both stocks offer dividend yields in excess of 5%, and investors might want to buy these two undervalued income plays at current levels.

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

3 Sectors, 3 Unusually Active Put Options to Sell

The markets have been on fire the past couple of weeks. While yesterday’s interest hike took some steam out of the markets, these three stocks and their options are unusually active and worthy of consideration.

Barchart

Should You Buy the Dip in Pfizer Stock? Here's What You Need to Know

US stock markets delivered stellar returns in the first half of the year and the Nasdaq 100 had its best first-half performance ever. However, Pfizer, whose COVID-19 vaccine made the company a household name recently fell to a 52-week low. Why is Pfizer stock going down and should you buy…

StockNews.com

Buy, Sell, or Hold: Pfizer Inc. (PFE)

Pfizer (PFE) continues to make significant strides in the pharmaceutical industry, given its recent acquisition and drug approvals. Is the stock a buy, sell, or hold now? Keep reading to find out….

StockNews.com

Adding These 2 Stocks to Your Portfolio Could End up Being a Genius Move

Due to still-high inflation and the Fed’s rate hikes, stock market volatility is anticipated to persist. However, fundamentally sound stocks Pfizer (PFE) and Honda Motor (HMC) could be a solid addition to your portfolio. Let's discuss.

StockNews.com

4 Robinhood Stocks to Buy Right Now

Zero-commission trading platform Robinhood is highly attractive to Gen Z and millennial investors. Therefore, stocks traded on the Robinhood platform are considered popular and trending. While all Robinhood stocks are not fundamentally sound, Taiwan Semiconductor Manufacturing (TSM), Pfizer (PFE), General Motors (GM), and Nokia (NOK) hold the potential to deliver…

StockNews.com

3 Best Stocks to Buy and Hold for a Lifetime

With inflation still alarmingly high, the Fed is poised to raise interest rates further. This is predicted to keep the stock market volatile. Amid this, investors should focus on their long-term strategies and buy fundamentally strong stocks Visa (V), Pfizer (PFE), and Molina Healthcare (MOH), which have solid growth potential.…

Tribune News Service

Pfizer to pay $43 billion for Seagen, set post-COVID course

Pfizer Inc. is purchasing cancer-drug maker Seagen Inc. for an enterprise value of $43 billion, using the biggest deal of the year to set its course out of the pandemic and back into mainstream pharma.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.